About Thynk Capital
Thynk Capital possesses a historical investment performance in the top 1% of venture capital. Focused on investments in early-stage pharma and biotech companies focused on extending HealthSpan and major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Cardiovascular, Diabetes, Frailty, and Rare Disease which affect over 25% of the population and growing at 10%/year.
Thynk Capital Headquarter Location
2620 South Maryland Parkway #844-14
Las Vegas, Nevada, 89158,
Thynk Capital Team
1 Team Member
Thynk Capital has 1 team member, including current Founder, Jim Plante.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.